文献速递主动脉疾病

聚四氟乙烯基腔内移植物医师改良修复主动脉瘤

Physician Modification of Polytetrafluoroethylene Based Endografts for Aortic Aneurysm Repair.
PubMed 文献 · J Endovasc Ther · 2025-07-11

OBJECTIVE: Physician-modified endografts (PMEGs) have provided an endovascular approach for repair of complex abdominal aortic aneurysms and thoracoabdominal aortic aneurysms.…

要点

  • PTFE-PMEG可用于紧急或急诊复杂主动脉瘤,内漏和主动脉相关死亡风险有限。
  • 术后内漏以2型为主,需再干预者少,30天生存率96.6%。
  • 需长期随访和前瞻性数据进一步验证。

核心结论

  • PTFE-PMEG可应用,内漏和主动脉相关死亡风险有限,需进一步长期随访和前瞻性研究。

主要发现

  • 改良移植物中83%为顺应性胸主动脉支架,17%为封堵器。
  • 术后内漏发生率24.1%,其中1例1C型内漏,6例2型内漏。
  • 3例患者需再干预。
  • 30天生存率96.6%,主动脉相关死亡免除率93.1%。

关键数值与推荐

  • 术后内漏发生率24.1%。
  • 30天生存率96.6%。
  • 主动脉相关死亡免除率93.1%。

临床怎么用

  • 对于不适合开放手术的复杂腹主动脉瘤和胸腹主动脉瘤,尤其紧急或急诊病例,可考虑PTFE-PMEG。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Physician-modified endografts (PMEGs) have provided an endovascular approach for repair of complex abdominal aortic aneurysms and thoracoabdominal aortic aneurysms. While the use of polyethylene terephthalate (Dacron)-based grafts is growing, we aimed to evaluate the use and outcomes of a polytetrafluoroethylene (PTFE)-based system for such cases. MATERIALS AND METHODS: In a retrospective, single-center cohort study from November 2021 to June 2024, treatment with physician-modified PTFE endograft for complex abdominal aortic aneurysms and thoracoabdominal aortic aneurysms was assessed. Stent modification and deployment was described and illustrated. Patient demographics, procedural details, and postoperative outcomes were collected and analyzed. Major adverse events, 30-day mortality, reintervention, endoleak, and aortic related mortality were analyzed in this cohort. RESULTS: Twenty-nine patients who received physician modified PTFE endograft were included in this study. Of these patients, 25 had urgent or emergent indication for intervention. Of the grafts modified, 83% were conformable thoracic stent graft devices and 17% were excluders. Endoleaks were observed in 24.1% of patients postoperatively; 1 patient had a type 1C endoleak and 6 patients had type 2 endoleak. Reinterventions were necessary in 3 patients. The 30-day survival observed in this study was 96.6% and freedom from total aortic related mortality was 93.1%. CONCLUSIONS: PTFE-PMEG can be employed with limited risk of endoleak and aortic related mortality. Further study involving long-term follow up and prospective data is necessary.Clinical ImpactPMEGs are increasingly utilized for patients unfit for open repair of complex abdominal aortic aneurysms and thoracoabdominal aortic aneurysms. Our study provides evidence in support of PMEGs for primarily medically urgent cases of this nature. We report limited complications, including endoleak or aortic related mortality, with a median follow up of over 7 months. While most of the current literature explores the use of Dacron-based grafts for PMEG, our study explores the use of PTFE-PMEG, which provides ease of manipulation and implantation. This technique can be employed with promising outcomes and necessitates further study by other vascular surgeons.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Zambetti BR, Shiva A, Hardy JT, et al. Physician Modification of Polytetrafluoroethylene Based Endografts for Aortic Aneurysm Repair. J Endovasc Ther. 2025. PMID: 40650361. doi:10.1177/15266028251353359

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。